Albany Molecular Profile |
21.74 |
|
Key Fundamentals
Return On Asset | 0.36 % | ||
Profit Margin | (8.78) % | ||
Operating Margin | 0.87 % |
Albany Molecular Against Markets
Albany Molecular Research, Inc., a contract research and manufacturing company, offer integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. more
| |||
Name | Albany Molecular Research | ||
CEO and President and Director | William MarthView All | ||
Analyst Consensus | |||
Macroaxis Advice | |||
Instrument | USA Stock View All | ||
Region | North America | ||
Location | NEW YORK, U.S.A | ||
Business Address | 26 Corporate Circle, Albany, NY 12203, United States | ||
Exchange | NASDAQ | ||
CIK Number | 01065087.0 | ||
CUSIP | 012423109 | ||
Industry | Business Services | ||
Benchmark | DOW | ||
Website | www.amriglobal.com | ||
Contact Number | 518 512 2000 | ||
Currency | USD - US Dollar |
Other Suggestions
View Currently Related Equities
Diversify with Albany Molecular Research
Build Optimal Portfolios
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Albany Molecular Research to your portfolio
Directors
Albany Molecular Corporate Directors
Arthur Roth Independent Director | |
Gerardo Gutierrez Director | |
Anthony Maddaluna Director, MBA |
Check also Trending Equities. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.